Pharmacokinetics of Herbal Compounds

The pharmacokinetics of herbal compounds describes what the body does to plant-derived substances over time: how they are absorbed, distributed to tissues, metabolized, and finally excreted. Many herbal constituents behave very differently from synthetic drugs, often showing poor and highly variable absorption, extensive metabolism, and rapid elimination, which together explain why measured blood levels are frequently low.

Definition

The pharmacokinetics of herbal compounds is the quantitative study of the time course of absorption, distribution, metabolism, and excretion of substances derived from medicinal plants and other botanical sources.

Scope

This entry covers the absorption, distribution, metabolism, and excretion (ADME) of chemically defined or partially defined constituents of herbal materials, using polyphenols and curcumin as worked examples, and the special challenges that mixtures and metabolism pose. It is a methodological and conceptual topic; it does not provide dosing or therapeutic recommendations.

Core questions

• How much of an ingested herbal constituent reaches the systemic circulation, and how is that fraction measured?
• Which absorption, metabolic, and transport barriers limit the exposure to plant constituents?
• How do food matrix, formulation, and gut microbiota modify the pharmacokinetics of phytochemicals?
• Why are plasma concentrations of compounds such as curcumin and many polyphenols typically low?

Key concepts

• Absorption, distribution, metabolism, excretion (ADME)
• Oral bioavailability and first-pass metabolism
• Phase II conjugation (glucuronidation, sulfation, methylation)
• Efflux transport (P-glycoprotein and related transporters)
• Gut microbiota-mediated biotransformation
• Inter-individual variability in exposure
• Formulation effects on absorption

Mechanisms

After ingestion, herbal constituents must survive the gut lumen, cross the intestinal epithelium, and pass the liver before reaching the systemic circulation. Polyphenols illustrate the typical pattern: they are extensively conjugated in the intestine and liver and are subject to microbial transformation in the colon, so that circulating species are often metabolites rather than the parent compound and concentrations are low (Manach et al., 2004; Manach et al., 2005). Curcumin is a much-cited case of poor systemic exposure driven by limited absorption, rapid metabolism, and quick elimination (Anand et al., 2007). Some constituents also influence the very enzymes and transporters that determine their own and other drugs' kinetics; St John's wort, for example, induces cytochrome P450 3A4 (Markowitz et al., 2003).

Clinical relevance

Because exposure to many herbal constituents is low and variable, pharmacokinetic data help interpret discrepancies between in vitro activity and observed effects, and they inform the anticipation of interactions when herbal products are taken with conventional medicines. This entry explains the principles behind such reasoning and is not a source of dosing or individualized treatment advice.

History

Interest in herbal pharmacokinetics grew as analytical methods became sensitive enough to measure plant constituents and their metabolites in biological fluids. Systematic reviews of polyphenol bioavailability in the mid-2000s consolidated the recognition that dietary and herbal phenolics are heavily metabolized and poorly available (Manach et al., 2004; Manach et al., 2005), and detailed studies of curcumin made low oral bioavailability a defining theme of the field (Anand et al., 2007).

Key figures

• Claudine Manach
• Augustin Scalbert
• Bharat B. Aggarwal
• John S. Markowitz

Seminal works

• manach-2004
• manach-2005
• anand-2007

Frequently asked questions

Why is the oral bioavailability of many herbal compounds so low?

Common reasons include poor solubility or permeability, extensive metabolism in the gut wall and liver, efflux back into the gut, and microbial breakdown in the colon, so that little of the parent compound reaches the bloodstream.

Are the compounds measured in blood the same as those ingested?

Often not. Many plant constituents, especially polyphenols, circulate mainly as conjugated or microbial metabolites rather than as the original molecule, which is important when interpreting pharmacokinetic studies.